MedPal AI (LON:MPAL) is a digital health and artificial intelligence company focused on wellness management and the operation of a Distance Selling Pharmacy making heathcare affordable for all.
It recently listed on AIM in August 2025 and with a sell-side Research note published on the company by Optimo Capital, valuing the company at 79.62p per share Vs 7p mid-price today.
Jason Drummond, Chief Executive Officer, discusses the symbiosis between its health and wellness app and the opportunity for the recently acquired pharmacy business:
- How the MedPal app aggregates multiple healthcare applications and can currently be accessed by 13 million gym members
- What the app’s inbuilt triage system can do in terms of assessing patient needs in seconds, escalating cases to a GP and fast-tracking medication requests
- Why the strategic focus on the £500 mln-a-month weight loss lifestyle has taken the company into the soon-to-be launched supplements business
- What experience the founder has, and why data protection is at the heart of the business
- Which courier organisation MedPal has selected so customers have a same day and next day prescription delivery service
- How the robotic dispensing technology and fulfilment capabilities at the Distance Selling Pharmacy gives MedPal AI a 365 degree approach to healthcare
- What shareholders can expect to be updated on in terms of revenue and conversions
Jason Drummond, chief executive and co-founder of MedPal AI was interviewed by Sarah Lowther for focusIR.
